EMEA-001313-PIP01-12-M12
Key facts
Invented name |
Zavicefta
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0258/2022
|
PIP number |
EMEA-001313-PIP01-12-M12
|
Pharmaceutical form(s) |
Powder for concentrate for solution for infusion
|
Condition(s) / indication(s) |
|
Route(s) of administration |
Intravenous use
|
Contact for public enquiries |
Pfizer Europe MA EEIG
Tel. +44 (0)1304 646 607 |
Decision type |
PM: decision on the application for modification of an agreed PIP
|